Amorphical’s Novel COVID-19 Oral and Inhaled Amorphous Calcium Carbonate (ACC) Treatment Significantly Reduces the Risk of ICU Admission and Mortality in Interim Analysis of a Phase II Study Involving Patients Hospitalized with Moderate-to-Severe COVID-19. (NIH Clinical Trial Registration No. NCT04900337) Outstanding preliminary results were revealed in an interim analysis of an on-going Phase II clinical …
As we get older, the calcium reservoir depletes in the body, the bones become weak and fragile. Density, the Amorphous Calcium Carbonate can help in this situation.
Amorphical is dedicated to developing therapeutic health and enhanced performance solutions for a range of diseases and human conditions
The Blue Crayfish is the inspiration for the discovery of Yossi Ben, the founder and CEO of Amorphical.
Every 3rd woman and every 5rd man suffer from calcium deficiency or osteoporosis. So, what is Amorphous Calcium Carbonate? What is its secret?
Inspired by the blue crayfish’s ability to rapidly build its shell using a unique form of calcium, an Israeli company says it could help develop novel pharmaceuticals and supplements.
Astronauts suffer from severe bone mass loss, when staying in microgravity environments. Density’s active component, ACC, enhances the activity of bone building cells (osteoblasts) both on earth and in space.